Watch Bristol-Myers to Pay $11 Billion to License Cancer Drug - Bloomberg

Jun 2nd, 2025

Bristol-Myers to Pay $11 Billion to License Cancer Drug

Bristol-Myers Squibb Co. will pay BioNTech SE as much as $11.1 billion to license a next-generation cancer drug, as competition intensifies in an area of oncology that seeks to harness the immune system to attack tumors. Bloomberg's Damian Garde reports.

Top Video

Duration:1:00

Trump, Xi Raise a Toast at End of Day One

Duration:1:56

Xi Presses Trump on Taiwan

Duration:0:54

Huang Says Summit 'Most Important in History'

Duration:0:33

Trump Invites China’s Xi to White House in September

Duration:3:26

Xi Says Common Interests Outweigh Differences

Insight with Haslinda Amin

Duration:1:45

Xi Greets Trump With Lavish Ceremony

The China Show

Duration:3:39

China's Xi Welcomes Trump at the Great Hall of the People

The China Show

Duration:10:33

Trump Making China Great Again?

Available on:

Listen onApple TV Listen onRoku Listen onSamsung TV Listen onFire TV Listen onAndroid TV Listen onRakuten TV Listen onHaystack News

Watch BTV in your area: